Radiological imaging for the diagnosis of bone metastases.

Primary neoplasms of the skeleton are rare, but metastatic involvement is, unfortunately, a common occurrence. This is particularly true for certain primary tumors. Skeletal metastases are clinically significant because of associated symptoms, complications such as pathological fracture and their profound significance for staging, treatment and prognosis. Detection of bone metastases is, thus, an important part of treatment planning. The frequency with which metastases are detected varies considerably with the type of primary tumor and with the methodology utilized for detection. Four main modalities are utilized clinically: plain film radiography, CT scan, nuclear imaging and magnetic resonance imaging. In this discussion, we will review literature on the radiology of skeletal metastases with respect to lesion detection, assessment of response to treatment and possible therapeutic implications. The bulk of the discussion will focus on MRI and nuclear studies since most of the recent advances have been made in these areas.

[1]  D E Dupuy,et al.  Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. , 2000, AJR. American journal of roentgenology.

[2]  M. Castillo,et al.  Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases. , 2000, AJNR. American journal of neuroradiology.

[3]  M. Fukunaga,et al.  [Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer]. , 2000, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[4]  R. Walker,et al.  Turbo STIR magnetic resonance imaging as a whole‐body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience , 2000, Journal of magnetic resonance imaging : JMRI.

[5]  J. Bergh,et al.  Evaluation of new sclerotic bone metastases in breast cancer patients during treatment , 2000 .

[6]  J. Damber,et al.  QUANTITATIVE BONE SCINTIGRAPHY , 2000 .

[7]  G. Grasselli,et al.  The role of bone SPET study in diagnosis of single vertebral metastases. , 2000, Anticancer research.

[8]  J. Damber,et al.  Quantitative bone scintigraphy: A methodological evaluation in prostate cancer , 2000, Acta radiologica.

[9]  J Kotzerke,et al.  Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  D. Bushnell,et al.  Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents. , 1999, Nuclear medicine communications.

[11]  M. Fukunaga,et al.  [Fundamental study of the detection of metastatic bone tumors with whole-body MR imaging]. , 1999, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[12]  H. Schirrmeister,et al.  Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Gleeson,et al.  Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases. , 1999, Clinical radiology.

[14]  G. Hanks,et al.  Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer. , 1999, Urology.

[15]  M. Dimopoulos,et al.  Bone lesions with soft-tissue mass: magnetic resonance imaging diagnosis of lymphomatous involvement of the bone marrow versus multiple myeloma and bone metastases. , 1999, Leukemia & lymphoma.

[16]  N. Budihna,et al.  The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine. , 1999, Clinical nuclear medicine.

[17]  R. Samant,et al.  Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. , 1999, Archives of surgery.

[18]  C. Asao,et al.  Diagnostic problems of evaluating vertebral metastasis from breast carcinoma with a higher degree of malignancy , 1999, Cancer.

[19]  K. Ryu,et al.  Spinal involvement of hematopoietic malignancies and metastasis: differentiation using MR imaging. , 1999, Clinical imaging.

[20]  Z Kusić,et al.  Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer. , 1999, Nuclear medicine communications.

[21]  E. Topuz,et al.  Response evaluation of bone metastases in breast cancer: value of magnetic resonance imaging. , 1999, Cancer investigation.

[22]  J. Damber,et al.  Predictive value of prostate-specific antigen, tumour stage and tumour grade for the outcome of bone scintigraphy in patients with newly diagnosed prostate cancer. , 1999, Scandinavian journal of urology and nephrology.

[23]  M. Reiser,et al.  Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. , 1999, Journal of computer assisted tomography.

[24]  P. Reuland,et al.  Differential diagnosis of metastases in bone scans: chemotherapy induced bone necrosis. , 1999, Nuklearmedizin. Nuclear medicine.

[25]  F. Kainberger,et al.  Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma? , 1999, Cancer.

[26]  C. Shapiro,et al.  Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patients. , 1999, Cancer investigation.

[27]  D. Brown,et al.  The value of a routine bone scan in a metastatic survey. , 1998, The Journal of otolaryngology.

[28]  J E Husband,et al.  T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: changes on treatment and correlation with response to therapy. , 1998, Clinical radiology.

[29]  S M Larson,et al.  A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  T. Au-yong,et al.  Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain , 1998, European Journal of Nuclear Medicine.

[31]  R. Coleman Monitoring of bone metastases. , 1998, European journal of cancer.

[32]  E. Melhem,et al.  A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. , 1997, AJR. American journal of roentgenology.

[33]  G. Åström,et al.  Assessment of suspected bone metastases , 1997, Acta radiologica.

[34]  M. Adkins Diagnosis of Bone and Joint Disorders , 1997 .

[35]  G. Maguire,et al.  Which patients with prostatic carcinoma require a staging bone scan? , 1997, British journal of urology.

[36]  S. Stephensen,et al.  Skeletal metastases of unknown origin: a retrospective analysis of 29 cases. , 1997, Acta orthopaedica Belgica.

[37]  G. Hortobagyi,et al.  Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. , 1996, The New England journal of medicine.

[38]  M. Reiser,et al.  Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. , 1996, AJR. American journal of roentgenology.

[39]  S. Larson,et al.  Detection of bony metastases of androgen-independent prostate cancer by PET-FDG. , 1996, Nuclear medicine and biology.

[40]  M. J. Fusselman,et al.  Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. , 1996, Radiology.

[41]  R. Wahl,et al.  Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. , 1996, Radiology.

[42]  S. Kosuda,et al.  Does bone SPECT actually have lower sensitivity for detecting vertebral metastasis than MRI? , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  S. Matetzky,et al.  Bilateral patellar metastases as the clinical presentation of bronchogenic adenocarcinoma. , 1996, The Journal of rheumatology.

[44]  P. Babin,et al.  Strategy for identifying primary malignancies with inaugural bone metastases. , 1995, Revue du rhumatisme.

[45]  I. Fogelman,et al.  The bone scan: where are we now? , 1995, Seminars in nuclear medicine.

[46]  A. Gangi,et al.  Injection of Alcohol into Bone Metastases under CT Guidance , 1994, Journal of computer assisted tomography.

[47]  H. Pretorius,et al.  Bone scintigraphy and multimodality imaging in bone neoplasia: strategies for imaging in the new health care climate. , 1994, Seminars in nuclear medicine.

[48]  R. Khorasani,et al.  Fast spin-echo MR in the detection of vertebral metastases: comparison of three sequences. , 1994, AJNR. American journal of neuroradiology.

[49]  Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies. , 1994, European urology.

[50]  MR imaging of vertebral metastases: evaluation of fat saturation imaging. , 1993, European journal of radiology.

[51]  D. Mitchell,et al.  Bull's-eyes and halos: useful MR discriminators of osseous metastases. , 1993, Radiology.

[52]  D. Vanel,et al.  Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. , 1992, Investigative radiology.

[53]  A. Elias,et al.  Gallium imaging in metastatic and recurrent soft-tissue sarcoma. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[54]  M. Simon,et al.  Evaluation, prognosis, and medical treatment considerations of metastatic bone tumors. , 1992, Orthopedics.

[55]  D. Renfrew,et al.  Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness. , 1992, AJR. American journal of roentgenology.

[56]  I. Carrió,et al.  Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  K. Sugimura,et al.  Assessing response to therapy of spinal metastases with gadolinium‐enhanced MR imaging , 1991, Journal of magnetic resonance imaging : JMRI.

[58]  P. Colletti,et al.  Spinal MR imaging in suspected metastases: correlation with skeletal scintigraphy. , 1991, Magnetic resonance imaging.

[59]  P. Stomper,et al.  Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  L. Peltier Diagnosis of Bone and Joint Disorders , 1988 .

[61]  D. Resnick Diagnosis of Bone and Joint Disorders , 1987 .

[62]  J. Hermans,et al.  REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT , 1987, The Lancet.

[63]  D. Rosenthal,et al.  Percutaneous biopsy of the cervical spine using CT guidance. , 1987, AJR. American journal of roentgenology.

[64]  W. Martin,et al.  Scintigraphy with gallium-67 citrate in staging of soft-tissue sarcomas of the extremity. , 1987, The Journal of bone and joint surgery. American volume.

[65]  G. Gottwald,et al.  [Treatment of bone metastases from breast cancer]. , 1981, Orvosi hetilap.

[66]  L. Gilula,et al.  Detection of bone-marrow metastases using quantitative computed tomography. , 1981, Radiology.

[67]  M. Fisher Lumbar spine metastasis in cervical carcinoma: a characteristic pattern. , 1980, Radiology.